Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms

Endocrine-related Cancer
Federica GrilloNIKE Group

Abstract

In the last few years, the therapeutic approach for neuroendocrine neoplasms (NENs) has changed dramatically following the approval of several novel targeted treatments. The multitarget tyrosine kinase inhibitor (MTKI), sunitinib malate, has been approved by Regulatory Agencies in pancreatic NENs. The MTKI class, however, includes several other molecules (approved for other conditions), which are currently being studied in NENs. An in-depth review on the studies published on the MTKIs in neuroendocrine tumors such as axitinib, cabozantinib, famitinib, lenvatinib, nintedanib, pazopanib, sorafenib and sulfatinib was performed. Furthermore, we extensively searched on the Clinical Trial Registries databases worldwide, in order to collect information on the ongoing clinical trials related to this topic. Our systematic analysis on emerging MTKIs in the treatment of gastroenteropancreatic and lung NENs identifies in vitro and in vivo studies, which demonstrate anti-tumor activity of diverse MTKIs on neuroendocrine cells and tumors. Moreover, for the first time in the literature, we report an updated view concerning the upcoming clinical trials in this field: presently, phase I, II and III clinical trials are ongoing and will include, ...Continue Reading

References

Mar 3, 1995·International Journal of Cancer. Journal International Du Cancer·O NilssonH Ahlman
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D HanahanJ Arbeit
May 18, 2001·Nature·P Blume-Jensen, T Hunter
Sep 24, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Irena Konstantinova, Eckhard Lammert
Nov 24, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristian Pietras, Douglas Hanahan
Jan 20, 2005·Surgery·Jamie Joseph Van Gompel, Herbert Chen
Aug 17, 2005·Current Cancer Drug Targets·M A Maynard, M Ohh
Dec 6, 2005·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·M RodallecY Menu
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L YauchLukas C Amler
Apr 25, 2006·Journal of Neuroendocrinology·T ShahM E Caplin
Dec 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Klaus PodarKenneth C Anderson
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yu TakahashiNobuyoshi Hiraoka
Mar 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoJaffer A Ajani
Jun 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoDouglas B Evans
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nilofer S AzadElise C Kohn
Aug 19, 2008·The Journal of Surgical Research·Gilles PoncetColette Roche
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anne CouvelardPierre Bedossa
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Herbert I HurwitzLini Pandite
Jun 24, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julian PaeslerKarl-Anton Kreuzer
Nov 10, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James E Ward, Walter M Stadler
Nov 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brunilde GrilPatricia S Steeg
Jan 20, 2011·World Journal of Gastroenterology : WJG·Patricia KuiperHein W Verspaget
Feb 11, 2011·The New England Journal of Medicine·Eric RaymondPhilippe Ruszniewski
Feb 11, 2011·The New England Journal of Medicine·James C YaoUNKNOWN RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group
Jan 24, 2012·Cell·Andrew D RhimBen Z Stanger
Feb 24, 2012·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Seiichi HosakaHideo Morioka
Jul 11, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A ChanMatthew H Kulke
Mar 12, 2013·Cancer Chemotherapy and Pharmacology·Jennifer A ChanMatthew H Kulke

❮ Previous
Next ❯

Citations

Dec 26, 2018·Expert Review of Clinical Pharmacology·Jordan M CloydTimothy M Pawlik
Apr 27, 2019·Endocrine Connections·Kosmas DaskalakisAnna Koumarianou
May 21, 2020·Nutrients·Jakub PobłockiMałgorzata Szczuko
Feb 27, 2020·International Journal of Molecular Sciences·Matilde MerolleMaria Laura Falchetti
Aug 22, 2020·World Journal of Gastroenterology : WJG·Gabriel Benyomo MpillaAsfar Sohail Azmi
Mar 15, 2019·Journal of Hematology & Oncology·Shuang QinKongming Wu
Sep 17, 2020·Reviews in Endocrine & Metabolic Disorders·Giovanni VitaleMaria Chiara Zatelli
Nov 26, 2019·Expert Opinion on Pharmacotherapy·Steven D ScovilleTimothy M Pawlik
Jan 16, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aaron T ScottJames R Howe
Mar 1, 2021·Current Treatment Options in Oncology·Chiara BorgaMatteo Fassan
Jun 19, 2021·Expert Review of Anticancer Therapy·Xiuhua LuZhongguang Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Supportive and Palliative Care
Ravi Kumar, Anil Kapoor
The New England Journal of Medicine
Eric RaymondPhilippe Ruszniewski
Therapeutic Advances in Urology
Shilpa Gupta, Philippe E Spiess
© 2022 Meta ULC. All rights reserved